Testing effectiveness (Phase 2)Study completedNCT00338416
What this trial is testing
An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks
Who this might be right for
CancerAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 115